COVID-19 vaccinations moving to single-shot approach
The U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to start unifying the strain composition for COVID-19 primary and booster vaccines on Jan. 26.
This is a step to coordinate and simplify the COVID-19 vaccination process, explained Luis Ostrosky, MD, infectious disease specialist with UT Physicians.
“The committee agreed to ‘harmonize’ the vaccine components going forward,” Ostrosky said. “It means future COVID vaccines, regardless of the manufacturer, will have the same formulation to target the same variants. They will all be designed as a single shot and not a series. The benefit is that people will have an easier time tracking their vaccination status.”